top of page
0e97ba796e439cace28d49f8ea76078f.jpeg
dna.png

....5 mins read

Pharmacogenomics & Adherence: Redefining Medication Management

Medication adherence is crucial for maintaining health and improving patients' quality of life. Despite its importance, many patients struggle to follow healthcare professionals' instructions, leading to suboptimal therapeutic outcomes and increased healthcare costs. To change this, we need to understand the barriers and develop personalise solutions for each individual.

Personalised medicine is transforming healthcare and offering new possibilities. By analysing each patient's genetic profile, scientists can design treatments that are more effective and easier to implement, improving medication outcomes.

Pharmacogenomics studies how an individual's DNA affects their response to medications. This approach allows us to:

  • Select the right medication: Every person is unique, and so should be their treatment.

  • Minimise side effects: Reducing risks helps patients feel safer with their treatment.

  • Personalise dosages for maximum effectiveness: Tailoring doses ensures optimal results.

Pharmacogenomics is revolutionising the way we approach medication management, emerging as a powerful tool for improving adherence by providing targeted solutions based on a patient’s genetic profile. This approach contributes to:

  • Prevention: Early risk detection through genetic testing.

  • Trust: Choosing the right treatment from the start, strengthening confidence in therapy.

  • Empowering Patients: Understanding how DNA influences treatment increases collaboration.

  • Building Trust: When patients see the benefits, they are more committed to adhering to their treatment.

Technology is making pharmacogenomics more accessible, providing healthcare professionals with tools for more efficient and personalised treatments. This approach goes beyond treatment it also contributes to prevention, creating a more effective and sustainable healthcare system.

Adherence is a challenge we can overcome through the collaboration of science, technology, and personalised care.

Written by:

2c3ebe741d8b12e36af0ffb6aba8b1b1.jpeg

Co-Founder, CSO, CTO

Theodosia Charitou

bottom of page